Silence Therapeutics plc Stock OTC Markets
Stocks
SLNCF
GB00B9GTXM62
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
10:43:13 2026-09-23 EDT
|
5-day change | 1st Jan Change | ||
| 4.000 USD | -.--% |
|
-.--% | +100.00% |
| Market Cap | 462M 611M 544M 507M 871M 58.79B 876M 6.12B 2.38B 29.99B 2.29B 2.24B 96.41B | P/E 2026 * |
-19.1x | P/E 2027 * | -15.3x |
|---|---|---|---|---|---|
| Enterprise Value | 329M 435M 387M 361M 620M 41.84B 623M 4.36B 1.7B 21.34B 1.63B 1.6B 68.62B | EV / Sales 2026 * |
1,019x | EV / Sales 2027 * | 383x |
| Free-Float |
69.35% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Silence Therapeutics plc
| 3 months | +166.67% | ||
| 6 months | +100.00% | ||
| Current year | +100.00% |
| 1 month | 4 |  | 4 |
| Current year | 1.06 | | 5.99 |
| 1 year | 1.06 | | 5.99 |
| 3 years | 0.5 | | 14.75 |
| 5 years | 0.5 | | 46.5 |
| 10 years | 0.5 | | 46.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Iain Ross
CEO | Chief Executive Officer | 72 | 2025-11-30 |
Rhonda Hellums
DFI | Director of Finance/CFO | 54 | 2022-01-31 |
Curtis Rambaran
CTO | Chief Tech/Sci/R&D Officer | - | 2020-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
David Lemus
BRD | Director/Board Member | 63 | 2018-06-20 |
Iain Ross
CHM | Chairman | 72 | 2003-12-31 |
Tim McInerney
BRD | Director/Board Member | 65 | 2025-05-04 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 641M | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.16B | |
| -0.37% | -3.88% | +19.75% | +78.35% | 57.39B | |
| +1.63% | +0.98% | +3.83% | +38.21% | 47.64B | |
| +0.50% | +1.32% | +344.62% | +753.25% | 44.29B | |
| +3.05% | -1.58% | +28.78% | +35.46% | 42.5B | |
| +1.00% | +0.22% | +5.17% | +113.80% | 40.71B | |
| -0.54% | +2.93% | +9.31% | +54.06% | 30.97B | |
| +1.56% | +4.53% | +31.34% | +26.92% | 28.53B | |
| +0.76% | -0.89% | -7.44% | -11.43% | 24.34B | |
| Average | +1.18% | -0.59% | +53.86% | +131.42% | 43.39B | |
| Weighted average by Cap. | +1.54% | -0.84% | +58.06% | +140.75% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 322K 426K 380K 354K 608K 41.05M 612K 4.28M 1.66M 20.94M 1.6M 1.57M 67.32M | 751K 992K 884K 824K 1.41M 95.55M 1.42M 9.95M 3.87M 48.74M 3.72M 3.64M 157M |
| Net income | -42.14M -55.71M -49.63M -46.29M -79.44M -5.36B -79.93M -559M -217M -2.74B -209M -205M -8.8B | -71.01M -93.89M -83.64M -78.01M -134M -9.04B -135M -942M -367M -4.61B -352M -345M -14.83B |
| Net Debt | -133M -176M -157M -146M -251M -16.94B -252M -1.77B -687M -8.64B -660M -646M -27.79B | -174M -230M -205M -191M -328M -22.16B -330M -2.31B -898M -11.3B -863M -845M -36.33B |
| Date | Price | Change | Volume |
|---|
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SLN Stock
- SLNCF Stock
Select your edition
All financial news and data tailored to specific country editions
